Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staccato Loxapine for Agitation in Bipolar I
NCT00721955Phase 3Completed
- Sponsor
- Alexza Pharmaceuticals Inc
- Start
- Jul 2008
- Primary completion
- Oct 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of loxapine in bipolar I disorder, sponsored by Alexza Pharmaceuticals Inc. Started Jul 2008; status: completed.
02
Drugs
loxapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00721955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00721955.